Symbol not found

:ALBO   00:00AM GMT
0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)NA
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$13.8 Million
Adjusted EPS-$1.83
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Albireo Pharma Inc Stock, :ALBO

53 State Street, 19th Floor, Boston, Massachusetts 02109
United States of America
Phone: +1.857.254.5555
Number of Employees:


Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-G�¶ran Gillberg on December 8, 2003 and is headquartered in Boston, MA.